6 published brand profiles in this category. Cite the individual brand profile for brand-specific facts.
Capricor Therapeutics - We offer a multi-stage pipeline exploring allogeneic cardiosphere-derived cells (CDCs) and exosome science for novel therapeutic approaches to treat a broad range of serious diseases. Capricor’s science is focused on cell and exosome-based biology, offering multiple modalities allowing us to create a new class of therapeutic medicines for patients.
Disc Medicine - Committed to turning scientific discoveries into effective medicines that will disrupt the current standard of care, alleviate suffering, and have a meaningful impact on the lives of patients and their families.
Mesoblast - Mesoblast is a clinical stage biotech company headquartered in Melbourne, Australia, founded in 2004.
Pliant Therapeutics - We are a clinical stage biopharmaceutical company discovering and developing novel therapies for the treatment of fibrosis and related diseases. By leveraging our powerful product discovery engine, we are discovering and developing novel therapeutics that seek to halt progression of fibrosis in specific tissues— ultimately, preserving organ function.
Therachon - Therachon is a clinical stage biotech company headquartered in Basel, Switzerland, founded in 2014.